Ventilator-associated pneumonia using a heated humidifier or a heat and moisture exchanger

ISRCTN ISRCTN88724583
DOI https://doi.org/10.1186/ISRCTN88724583
Secondary identifying numbers N/A
Submission date
02/05/2006
Registration date
09/06/2006
Last edited
06/01/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Leonardo Lorente
Scientific

Intensive Care Unit
Hospital Universitario de Canarias
Ofra s/n
La Laguna
38320
Spain

Study information

Study designRandomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific titleVentilator-associated pneumonia using a heated humidifier or a heat and moisture exchanger
Study objectivesPatients mechanically ventilated for more than 5 days may develop lower ventilator-associated pneumonia with a heated humidifier than with a heat and moisture exchanger.
Ethics approval(s)Ethics Committee of the University Hospital of the Canaries on 05/02/2004
Health condition(s) or problem(s) studiedPneumonia
InterventionHumidification with a heated humidifier or a heat and moisture exchanger
Intervention typeOther
Primary outcome measureHeated humidifier decreases ventilator-associated pneumonia incidence
Secondary outcome measuresHeated humidifier decreases secondary endogenous ventilator-associated pneumonia
Overall study start date01/01/2005
Completion date31/12/2005

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants120
Total final enrolment120
Key inclusion criteriaPatients expected to require mechanical ventilation for more than 5 days
Key exclusion criteria1. Age <18 years
2. Human immunodeficiency virus (HIV)
3. Blood leukocytes counts <1000 cells per mm^3
4. Solid or hematological tumour
5. Immunosuppressive therapy
Date of first enrolment01/01/2005
Date of final enrolment31/12/2005

Locations

Countries of recruitment

  • Spain

Study participating centre

Intensive Care Unit
La Laguna
38320
Spain

Sponsor information

University Hospital of the Canaries (Hospital Universitario de Canarias) (Spain)
University/education

Ofra s/n
La Laguna
38320
Spain

ROR logo "ROR" https://ror.org/05qndj312

Funders

Funder type

University/education

University Hospital of the Canarias

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/11/2006 Yes No

Editorial Notes

06/01/2021: Total final enrolment added.